TELCON RF PHARMACEUTICAL. Inc.

KOSDAQ 200230.KQ

TELCON RF PHARMACEUTICAL. Inc. Shareholders' Equity for the year ending December 31, 2023: USD 80.22 M

TELCON RF PHARMACEUTICAL. Inc. Shareholders' Equity is USD 80.22 M for the year ending December 31, 2023, a 20.72% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

TELCON RF PHARMACEUTICAL. Inc. Shareholders' Equity for the year ending December 31, 2022 was USD 66.46 M, a -25.50% change year over year.
TELCON RF PHARMACEUTICAL. Inc. Shareholders' Equity for the year ending December 31, 2021 was USD 89.21 M, a 6.39% change year over year.
TELCON RF PHARMACEUTICAL. Inc. Shareholders' Equity for the year ending December 31, 2020 was USD 83.85 M, a -14.68% change year over year.
TELCON RF PHARMACEUTICAL. Inc. Shareholders' Equity for the year ending December 31, 2019 was USD 98.28 M, a -28.63% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

KOSDAQ: 200230.KQ

TELCON RF PHARMACEUTICAL. Inc.

CEO	Jin-Hun Lim
IPO Date	Nov. 24, 2014
Location	South Korea
Headquarters	54, Gongse-ro
Employees	125
Sector	Communication Services
Industries Satellite Aerospace Automotive Parts Ceramics Composite Materials Defense & Military Hardware & Electronics Telecommunications & Networking

Description

TELCON RF PHARMACEUTICAL. Inc. develops, produces, and sells RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is based in Yongin-si, South Korea.

Key trends

Past 5 years